NASDAQ:ONC

BeOne Dips on Wall Street After Cancer Results, Market Looks On
·······

BeOne Dips on Wall Street After Cancer Results, Market Looks On

BeOne Medicines shares fell 2.7% to $291.98 Thursday afternoon despite positive late-stage cancer trial data, while the Nasdaq Biotechnology Index rose 1.1%. The Phase 3 HERIZON-GEA-01 trial showed BeOne’s ZIIHERA combo reached median overall survival of 26.4 months versus 19.2 months for the control. Investors appeared cautious ahead of more data expected at the ASCO meeting next week.
May 28, 2026

Stock Market Today

  • Viking Mines Advances Linka Tungsten Project with Premium 62.5% WO3 Concentrate
    May 28, 2026, 5:08 PM EDT. Viking Mines (ASX:VKA) announced a significant improvement in the Linka tungsten project in Nevada with metallurgical testwork yielding a premium 62.5% tungsten trioxide (WO3) concentrate at 59.8% recovery from a 1.2% feed grade. This marks a substantial increase from previous results of 56.4% WO3 at 46.0% recovery. The concentrate quality approaches Almonty's Sangdong mine in Korea and surpasses recent figures from Spain's Barruecopardo mine (53.2% recovery). Viking's step-change supports a low-cost "Rapid Start" development model emphasizing physical gravity separation over chemical processing, enabling faster project advancement. Validation tests on a larger 10kg sample scale de-risk the metallurgical flowsheet ahead of the planned maiden drilling campaign. Tungsten prices remain near all-time highs at around US$3,050 per metric tonne unit (mtu), bolstering the project's economic outlook.